GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Caliber Imaging & Diagnostics Inc (OTCPK:LCDX) » Definitions » Return-on-Tangible-Equity

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Return-on-Tangible-Equity : 0.00% (As of Mar. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Caliber Imaging & Diagnostics Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Caliber Imaging & Diagnostics's annualized net income for the quarter that ended in Mar. 2014 was $-7.29 Mil. Caliber Imaging & Diagnostics's average shareholder tangible equity for the quarter that ended in Mar. 2014 was $-13.34 Mil. Therefore, Caliber Imaging & Diagnostics's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2014 was N/A%.

The historical rank and industry rank for Caliber Imaging & Diagnostics's Return-on-Tangible-Equity or its related term are showing as below:

LCDX's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.97
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Caliber Imaging & Diagnostics Return-on-Tangible-Equity Historical Data

The historical data trend for Caliber Imaging & Diagnostics's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliber Imaging & Diagnostics Return-on-Tangible-Equity Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Return-on-Tangible-Equity
- - - - -

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Caliber Imaging & Diagnostics's Return-on-Tangible-Equity

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliber Imaging & Diagnostics's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's Return-on-Tangible-Equity falls into.



Caliber Imaging & Diagnostics Return-on-Tangible-Equity Calculation

Caliber Imaging & Diagnostics's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2013 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=-5.479/( (-7.707+-12.493 )/ 2 )
=-5.479/-10.1
=N/A %

Caliber Imaging & Diagnostics's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2014 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2014 )  (Q: Dec. 2013 )(Q: Mar. 2014 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2014 )  (Q: Dec. 2013 )(Q: Mar. 2014 )
=-7.292/( (-12.493+-14.182)/ 2 )
=-7.292/-13.3375
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2014) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Caliber Imaging & Diagnostics  (OTCPK:LCDX) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Caliber Imaging & Diagnostics Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Caliber Imaging & Diagnostics's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
100 Burtt Road, Suite 203, Andover, MA, USA, 01810
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.
Executives
Paul Stuka director C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
William J Shea director, 10 percent owner 11825 N PENNSYLVANIA ST, CARMEL IN 46032
Kevin M Cronin director
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
Martin Joseph Joyce officer: Chief Financial Officer 1050 HINGHAM STREET, ROCKLAND MA 02370
Matthew S Cox director 58 OAKWOOD DRIVE, CHAPEL HILL NC 27517

Caliber Imaging & Diagnostics (Caliber Imaging & Diagnostics) Headlines